Literature DB >> 7189330

A weak negative inotropic effect of protamine sulfate upon the isolated canine heart muscle.

N Iwatsuki, S Matsukawa, K Iwatsuki.   

Abstract

The direct effect of protamine sulfate upon myocardial inotropism was studied using an isolated canine heart muscle preparation. Isometric force (F) was decreased to 87.6 +/- 1.2% of control values by a concentration of 50 x 10(-3) g/L protamine, which is approximately equal to the estimated serum concentration of protamine when administered clinically in doses of 4 mg/kg. The decrease in F was accompanied by a decrease in the maximum velocity of force development (dF/dt) but no alteration in time to peak force. Administration of the preservative of protamine sulfate did not alter F and dF/dt. This suggests that protamine produces a direct negative inotropic effect, mediated by a decrease in intensity but not by a decrease in duration of the active state.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189330

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Impaired myocardial function and oxygen utilization due to protamine sulfate in an isolated rabbit heart preparation.

Authors:  T W Wakefield; L E Bies; S K Wrobleski; S F Bolling; J C Stanley; M M Kirsh
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

2.  Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs.

Authors:  R K Stoelting; D P Henry; K M Verburg; R L McCammon; R D King; J W Brown
Journal:  Can Anaesth Soc J       Date:  1984-09

3.  The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.

Authors:  B Milne; K Rogers; F Cervenko; T Salerno
Journal:  Can Anaesth Soc J       Date:  1983-07

4.  Effect of protamine on plasma ionized calcium in the dog.

Authors:  R M Jones; A B Hill; M L Nahrwold; A R Tait
Journal:  Can Anaesth Soc J       Date:  1982-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.